- Report
- September 2023
- 25 Pages
Australia
From €825EUR$916USD£732GBP
- Report
- September 2023
- 114 Pages
Norway
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2023
- 100 Pages
Argentina
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2023
- 108 Pages
Greece
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2023
- 119 Pages
Italy
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2023
- 105 Pages
Netherlands
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2023
- 27 Pages
Italy
From €825EUR$916USD£732GBP
- Report
- September 2021
- 119 Pages
Russia
From €2200EUR$2,442USD£1,953GBP
- Report
- September 2019
- 100 Pages
Global
From €4628EUR$4,795USD£3,970GBP
- Report
- July 2023
- 223 Pages
China
From €3861EUR$4,000USD£3,312GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- October 2023
- 94 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- May 2022
- 99 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- October 2023
- 108 Pages
Peru
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 25 Pages
Peru
From €825EUR$916USD£732GBP
- Report
- October 2023
- 80 Pages
Latvia
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 83 Pages
Lithuania
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 78 Pages
North Macedonia
From €2200EUR$2,442USD£1,953GBP
- Report
- October 2023
- 24 Pages
Sweden
From €825EUR$916USD£732GBP
- Report
- October 2023
- 23 Pages
Latvia
From €825EUR$916USD£732GBP
The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more
